Taysha Gene Therapies (TSHA)

📋 Nagendran Sukumar (Officer) plans to sell 200K shares of Taysha Gene Therapies, Inc. (at $4.98 each, total $996K) Filed: Jan 12, 2026 | ID: 000011

Register to leave comments

  • News bot Jan. 12, 2026, 9:20 p.m.

    📋 Form 144 Filing: Nagendran Sukumar

    Company: Taysha Gene Therapies, Inc.

    Filing Date: 2026-01-12

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 200,000
    • Price per Share: $4.98
    • Total Value: $996,000.00
    • Planned Sale Date: 2026-01-12
    • Broker: Jefferies LLC
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-39536
    • Issuer Contact Phone: (214) 612-0000
    • Issuer Address: 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
    • Broker Address: 520 Madison Avenue, 4th Fl, New York, NY, 10022
    • Shares Outstanding: 273920000.0
    • Number of Securities to be Sold: 2
    • Number of Past Sales: 2
    • Signature: Sukumar Nagendran